Agree Realty logo

Agree RealtyNYSE: ADC

Profile

Industry:

Retail

Country:

United States

IPO:

15 April 1994

Next earnings report:

13 February 2025

Last dividends:

31 October 2024

Next dividends:

29 November 2024
$8.39 B
0%vs. 3y high
82%vs. sector
0%vs. 3y high
75%vs. sector
-3%vs. 3y high
63%vs. sector
-17%vs. 3y high
95%vs. sector

Price

after hours | Thu, 21 Nov 2024 00:41:53 GMT
$77.75+$0.23(+0.30%)
$154.33 M$158.25 M
$154.33 M$44.38 M

Analysts recommendations

Institutional Ownership

ADC Latest News

Forget The Election: 3 REITs To Buy Today
seekingalpha.com11 November 2024 Sentiment: POSITIVE

Macroeconomics trumps politics. REITs are cheap and set to benefit from rate cuts. Here are 3 REITs that win no matter what.

Buy The Dip: Big Dividend Growth Stocks Getting Way Too Cheap
seekingalpha.com11 November 2024 Sentiment: POSITIVE

High-yield dividend growth stocks have been on a strong run over the past four months. However, there are several that have not participated in the rally and have even dipped sharply in some cases. We share three examples of high-yielding dividend growers that have strong outlooks but are deeply discounted due to short-term issues.

IDEAYA Announces Development Candidate Nomination of IDE034, a Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispecific ADC and Option Exercise with Biocytogen
prnewswire.com11 November 2024 Sentiment: POSITIVE

Nominated IDE034 (BCG034) as a development candidate, a potential first-in-class B7H3/PTK7 topo-I-payload bispecific antibody drug conjugate (BsADC) Option exercised for an exclusive worldwide license for IDE034 from Biocytogen Targeting an IND-filing for IDE034 in 2025 to enable first-in-human clinical evaluation of B7H3/PTK7 topo-I-payload BsADC program IDE034 has the potential to be developed as a monotherapy and in combination with IDEAYA's PARG inhibitor IDE161 B7H3/PTK7 co-expression in lung, colorectal, and head and neck cancer, has been reported at approximately 30%, 46% and 27%, respectively SOUTH SAN FRANCISCO, Calif. and BEIJING , Nov. 11, 2024 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced the selection of IDE034, a potential first-in-class B7H3/PTK7 topo-I-payload BsADC, as a development candidate and the exercise of its option for an exclusive worldwide license from Biocytogen Pharmaceuticals (Beijing) Co., Ltd.

The Dark Side Of REIT Investments
seekingalpha.com09 November 2024 Sentiment: NEGATIVE

Not everything is perfect in REIT world. On the contrary, this is a sector in which you need to be very selective. Here are 5 types of REITs to avoid at all cost:

Looking for Passive Income? These 3 High-Yield Dividend Stocks Cut You a Check Monthly.
fool.com09 November 2024 Sentiment: POSITIVE

Dividend-paying stocks consistently outperform those that don't pay a dividend.

ADC Therapeutics to Present at November Investor Conferences
prnewswire.com04 November 2024 Sentiment: POSITIVE

LAUSANNE, Switzerland , Nov. 4, 2024 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced participation in two investor conferences in November: Guggenheim Securities Healthcare Innovation Conference Date: November 11, 2024 Presentation Time: 11:00 a.m. ET Format: Fireside ChatSpeaker: Ameet Mallik, Chief Executive Officer Jefferies London Healthcare Conference Date: November 19, 2024 Presentation Time: 11:00 a.m.

Antibody-Drug Conjugates (ADC) Technology Research and Global Markets Report 2024-2025 & 2029 with Profiles of Leading Players - F. Hoffmann-La Roche.
globenewswire.com04 November 2024 Sentiment: POSITIVE

Dublin, Nov. 04, 2024 (GLOBE NEWSWIRE) -- The "Antibody-Drug Conjugates: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
prnewswire.com01 November 2024 Sentiment: POSITIVE

LAUSANNE, Switzerland , Nov. 1, 2024 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced that the Company has made grants of options to purchase an aggregate of 42,000 of the Company's common shares to two new employees on November 1, 2024 (each, a "Grant"). The Grants were offered as material inducement to the employees' employment.

ADC Therapeutics to Host Third Quarter 2024 Financial Results Conference Call on November 7, 2024
prnewswire.com31 October 2024 Sentiment: POSITIVE

LAUSANNE, Switzerland , Oct. 31, 2024 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced that it will host a conference call and live webcast on Thursday, November 7, 2024, at 8:30 a.m. EST to report financial results for the third quarter 2024 and provide operational updates.

2 REITs To Avoid And 1 Strong Buy
seekingalpha.com29 October 2024 Sentiment: NEUTRAL

Not all REITs are worth buying. This is a vast sector, and you need to be very selective. I highlight 2 REITs to sell and a better alternative.

What type of business is Agree Realty?

Agree Realty Corporation (the “Company”), a Maryland corporation, is a fully integrated real estate investment trust (“REIT”) primarily focused on the ownership, acquisition, development and management of retail properties net leased to industry leading tenants. The Company was founded in 1971 by its current Executive Chairman, Richard Agree, and its common stock was listed on the New York Stock Exchange in 1994. As of March 31, 2024, the Company owned 2,161 properties, with a total gross leasable area (“GLA”) of approximately 44.9 million square feet.

What sector is Agree Realty in?

Agree Realty is in the Real Estate sector

What industry is Agree Realty in?

Agree Realty is in the Retail industry

What country is Agree Realty from?

Agree Realty is headquartered in United States

When did Agree Realty go public?

Agree Realty initial public offering (IPO) was on 15 April 1994

What is Agree Realty website?

https://www.agreerealty.com

Is Agree Realty in the S&P 500?

No, Agree Realty is not included in the S&P 500 index

Is Agree Realty in the NASDAQ 100?

No, Agree Realty is not included in the NASDAQ 100 index

Is Agree Realty in the Dow Jones?

No, Agree Realty is not included in the Dow Jones index

When was Agree Realty the previous earnings report?

No data

When does Agree Realty earnings report?

The next expected earnings date for Agree Realty is 13 February 2025